Ion Channels and Transporters as Druggable Targets in Oncology
A specialised R&D-focused pharmaceutical company seeks to engage with Academic Experts, Centres of Excellence and University Spin‑Outs in order to acquire unique and consistent target validation data related to ion channels or transporters in oncology.
Our Client is seeking to collaborate with partners having data proving robust efficacy in cancer cells and/or tumor-bearing mice in response to genetic or pharmacologic interventions against ion channels or transporters. There is no limitation on cancer types and modes of action.
To see the full details and submit your response please register now
Benefits of registration:
- Receive updates on the latest industry calls
- Quickly and easily respond to calls via your dashboard
- Build your academic profile